Source: International Congress 2015 – IIPs: orphan
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Dirk Steffen Koschel (Radebeul, Germany), Jan Holfert, Bärbel Wiedemann, Gert Höffken, Dirk Koschel. Specific IgG antibodies in chronic hypersensitivity pneumonitis. Eur Respir J 2015; 46: Suppl. 59, 3821

Member's Comments

No comment yet.

Related content which might interest you: Rituximab for the treatment of chronic hypersensitivity pneumonitis Source: International Congress 2015 – Interstitial lung diseases I Year: 2015 Use of fluoroenzyme immunoassay in the diagnosis of bird fancier’s hypersensitivity pneumonitis Source: International Congress 2016 – Immune responses in the lung Year: 2016 Treatment response in hypersensitivity pneumonitis Source: International Congress 2016 – Orphan diseases II Year: 2016 Steroid sparing effect of anti-IgE antibody in allergic bronchopulmonary aspergillosis (ABPA) complicating cystic fibrosis Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children Year: 2013 Clinical features of usual interstitial pneumonia with anti-neutrophil cytoplasmic antibody in comparison with idiopathic pulmonary fibrosis Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014 Risk of hypersensitivity pneumonitis and interstitial lung diseases among pigeon breeders Source: Eur Respir J 2016; 48: 818-825 Year: 2016 Expression of heat shock protein 47 in chronic hypersensitivity pneumonitis Source: International Congress 2015 – Interstitial lung diseases I Year: 2015 Usual interstitial pneumonia pattern in chronic hypersensitivity pneumonitis Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 Interstitial pneumonia vs. hypersensitivity pneumonitis with autoimmune features Source: International Congress 2017 – ILDs: clinical problems Year: 2017 Description of a murine model of acute pneumonitis hypersensitivity to pigeon serum Source: International Congress 2014 – ILDs 2 Year: 2014 Use of acetylcysteinein the treatment of patients with exogenic allergic alveolitis (EAA) Source: Annual Congress 2013 –Diffuse parenchymal lung disease III Year: 2013 Anti-parietal cell autoimmunity in IPF patients Source: International Congress 2016 – IPF: from pathogenesis to treatment I Year: 2016 Comparison of two murine models of acute and chronic hypersensitivity pneumonitis due to pigeon serum exposure Source: International Congress 2015 – Occupational and environmental effects: in vitro and animal models Year: 2015 Chronic hypersensitivity pneumonitis with familial history of interstitial lung disease Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease Year: 2010 Utility of myositis related antibodies in interstitial lung disease and suspected autoimmunity. Source: International Congress 2019 – From biomarkers to treatment of immune-mediated interstitial lung disease: what’s new? Year: 2019 Liposomal local therapy of upper respiratory tract involvement in ANCA associated vasculitis Source: International Congress 2014 – Biomarkers of asthma and clinical immunology Year: 2014 Histopathological findings of biopsies from patients with extrinsic allergic alveolitis (hipersensitivity pneumonia) in subacute or chronic phase Source: Annual Congress 2013 –Diffuse parenchymal lung disease III Year: 2013 Change of lung function in severe eosinophilic asthma undergoing treatment with anti-interleukin-5 monoclonal antibody Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures Year: 2018 Pulmonary manifestations of immunoglobulin G4-related sclerosing disease Source: Eur Respir J 2011; 39: 180-186 Year: 2012 Pulmonary manifestations of immunoglobulin G4-related sclerosing disease Source: Eur Respir J 2012; 39: 180-186 Year: 2012